CR Medical (01515) Schedules 24 March 2026 Board Meeting to Approve FY 2025 Results and Consider Final Dividend

Bulletin Express03-09

China Resources Medical Holdings Company Limited (CR Medical, 01515) has announced that its board of directors will convene on 24 March 2026.

Key agenda items include:

1. Reviewing and approving the consolidated annual results for the financial year ended 31 December 2025.

2. Deliberating on the recommendation of a final dividend, if any.

3. Addressing any additional corporate matters.

The announcement, dated 9 March 2026 and signed by Chairman Yu Hai, also lists the current board composition: four executive directors (Yu Hai, Zhang Chuang, Wang Yuexing, Wu Xinchun), one non-executive director (Ge Lu), and four independent non-executive directors (Wu Ting Yuk, Anthony; Fu Tingmei; Zhou Peng; Lo Wing Sze).

The forthcoming board meeting will determine the publication timetable for CR Medical’s FY 2025 results and any proposed dividend distribution.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment